Your browser doesn't support javascript.
loading
EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old.
Agache, Ioana; Akdis, Cezmi A; Akdis, Mubeccel; Brockow, Knut; Chivato, Tomas; Del Giacco, Stefano; Eiwegger, Thomas; Eyerich, Kilian; Giménez-Arnau, Ana; Gutermuth, Jan; Guttman-Yassky, Emma; Maurer, Marcus; Ogg, Graham; Ong, Peck Y; O'Mahony, Liam; Schwarze, Jürgen; Warner, Amena; Werfel, Thomas; Palomares, Oscar; Jutel, Marek.
Afiliação
  • Agache I; Faculty of Medicine, Transylvania University, Brasov, Romania.
  • Akdis CA; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Akdis M; Christine-Kühne-Center for Allergy Research and Education (CK-CARE, Davos, Switzerland.
  • Brockow K; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Chivato T; Department of Dermatology and Allergology Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
  • Del Giacco S; School of Medicine, University CEU San Pablo, Madrid, Spain.
  • Eiwegger T; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Eyerich K; Translational Medicine Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada.
  • Giménez-Arnau A; Department of Immunology, University of Toronto, Toronto, ON, Canada.
  • Gutermuth J; Karl Landsteiner University of Health Sciences, Krems, Austria.
  • Guttman-Yassky E; Department of Paediatrics, University Hospital St. Pölten, Pölten, Austria.
  • Maurer M; Department of Dermatology and Allergy Biederstein, Technical University of Munich, Munich, Germany.
  • Ogg G; Department of Dermatology, Hospital del Mar- Institut Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Ong PY; Department of Dermatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB, Brussels, Belgium.
  • O'Mahony L; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Schwarze J; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Warner A; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Oxford NIHR Biomedical Research Centre, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Werfel T; Division of Clinical Immunology & Allergy, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Palomares O; Departments of Medicine and Microbiology, APC Microbiome Ireland, University College Cork, Cork, Ireland.
  • Jutel M; Centre for Inflammation Research, Child Life and Health, The University of Edinburgh, Edinburgh, UK.
Allergy ; 77(1): 17-38, 2022 01.
Article em En | MEDLINE | ID: mdl-34324716
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Produtos Biológicos / Antialérgicos / Urticária Crônica Tipo de estudo: Guideline Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Allergy Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Romênia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Produtos Biológicos / Antialérgicos / Urticária Crônica Tipo de estudo: Guideline Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Allergy Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Romênia